WG Biotech ApS: Financial statements 2020
CVR: 36940131
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 502,621,000 compared with DKK 389,482,000 the year before. Equity in the 2020 report amounted to DKK 1,644,295,000. The solvency ratio was 99.5%.
- Profit/Loss
- DKK 502,621,000
- Equity
- DKK 1,644,295,000
- Total Assets
- DKK 1,652,037,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 502.6 mio. | 1.6 mia. | - |
| 2019 | - | - | 389.5 mio. | 1.1 mia. | - |
| 2018 | - | - | 657.5 mio. | 657 mio. | - |
| 2017 | - | - | -220 t. | -425 t. | - |
| 2016 | - | - | -265 t. | -204 t. | - |
Official annual report
How creditworthy is WG Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
WG Biotech ApS has published its annual report for 2019. The net result was DKK 389,482,000.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.